Clinical Trials Logo

Clinical Trial Summary

Prevention of post spinal anesthesia shivering during cesarean section with its associated discomfort, distress, aggravation of pain, increased metabolic demands, and increased oxygen consumption


Clinical Trial Description

Shivering is one of the most important periperative complications seen in clinical practice. Several mechanisms have been postulated for its pathogenesis. Anesthetic-induced inhibition of thermoregulation resulting in hypothermia is an important cause of post anesthesia shivering, uncontrolled spinal reflexes, and cutaneous vasodilation are the other suggested mechanisms involved in the pathogenesis of shivering. Opioid receptors, α2 receptors, and serotonergic receptors also are involved of shivering. Various drugs were studied for their potential role in prevention of peri-operative shivering such as tramadol, dexmedetomidine, ondansetron, ketamine, and pethidine. We decided to perform a well-designed study to compare clonidine and granisetron which has been recently introduced as drugs for prevention and control of shivering after spinal anesthesia. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06031090
Study type Interventional
Source Zagazig University
Contact Heba M Fathi, M.D
Phone 00201000143938
Email heba_elgendi@yahoo.com
Status Recruiting
Phase Phase 2
Start date March 5, 2023
Completion date October 30, 2023

See also
  Status Clinical Trial Phase
Completed NCT04266145 - Intravenous Versus Perineural Dexmedetomidine as Adjuvant in Adductor Canal Block for Total Knee Arthroplasty N/A